Preferred Label : concizumab;

MeSH note : blocked the interaction between FXa and factor pathway inhibitor in a rabbit hemophilia model;

MeSH hyponym : monoclonal antibody 2021;

Is substance : O;

UNII : 68603V9EAF;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/alhemo
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
concizumab
concizumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/concizumab
2024
false
false
false
France
French
concizumab
guidelines for drug use
summary of product characteristics
package leaflet
technical report
hemophilia A
hemophilia B
hemorrhage
adolescent

---
https://www.has-sante.fr/jcms/p_3563330/fr/alhemo-concizumab-hemophilie-a-et-b-avec-inhibiteurs
2024
false
false
false
France
Hereditary factor VIII deficiency disease with inhibitor (disorder)
hemophilia A
Hereditary factor IX deficiency disease with inhibitor (disorder)
evaluation of the transparency committee
concizumab
hemophilia B

---
https://www.has-sante.fr/jcms/p_3466237/fr/alhemo-concizumab-hemophilie-a-et-b-avec-inhibiteurs
2023
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
Hereditary factor VIII deficiency disease with inhibitor (disorder)
hemophilia A
hemorrhage
adolescent
adult
Hereditary factor IX deficiency disease with inhibitor (disorder)
concizumab
evaluation of the transparency committee
hemophilia B
concizumab

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-05-09-2023-sur-le-medicament-alhemo-dans-le-cadre-dune-demande-daap
2023
false
false
false
France
French
drug information
concizumab
package leaflet
summary of product characteristics

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.